Clinical Trial Update: Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating PF-06817024 in healthy subjects, and in patients with chronic rhinosinusitis with nasal polyps and atopic dermatitis has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• PF-06817024 (PF-06817024)

Snippet

Sponsor: Pfizer | Conditions: Healthy, Chronic Rhinosinusitis With Nasal Polyps | Phase 1 | Status: COMPLETED | Results posted: 2022-05-19